Literature DB >> 33471653

Understanding Osteoporosis Screening Practices in Men: A Nationwide Physician Survey.

Palak Choksi1, Brittany L Gay1, David Reyes-Gastelum1, Megan R Haymart1, Maria Papaleontiou2.   

Abstract

OBJECTIVE: To understand osteoporosis screening practices, particularly in men, by a diverse cohort of physicians, including primary care physicians, endocrinologists, and geriatricians.
METHODS: We surveyed randomly selected members of the American Academy of Family Practice, Endocrine Society, and American Geriatrics Society. Respondents were asked to rate how often they would screen for osteoporosis in four different clinical scenarios by ordering a bone density scan. Multivariable logistic regression analyses were conducted to determine factors associated with offering osteoporosis screening in men in each clinical scenario. Physicians were also asked to note factors that would lead to osteoporosis screening in men.
RESULTS: Response rate was 63% (359/566). While 90% respondents reported that they would always or frequently screen for osteoporosis in a 65-year-old post-menopausal woman, only 22% reported they would screen a 74-year-old man with no significant past medical history. Endocrinologists were more likely to screen a 74-year-old man compared to primary care physicians (odds ratio, 2.32; 95% confidence interval, 1.10 to 4.88). In addition to chronic steroid use (94%), history of nontraumatic fractures (88%), and androgen-deprivation therapy for prostate cancer (82%), more than half the physicians reported suppressive doses of thyroid hormone (64%) and history of falls (52%) as factors leading to screening for osteoporosis in men.
CONCLUSIONS: Our survey results highlight heterogeneity in osteoporosis screening in men, with underscreening in some scenarios compared to women, and identify factors that lead to screening in men. These findings can help design interventions to improve osteoporosis screening in men.
© 2020 American Association of Clinical Endocrinologists. Published by Elsevier, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33471653      PMCID: PMC7755710          DOI: 10.4158/EP-2020-0123

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  36 in total

1.  Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.

Authors:  Maria Antonelli; Douglas Einstadter; Marina Magrey
Journal:  J Clin Densitom       Date:  2014-03-20       Impact factor: 2.617

2.  Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Vincenza Snow; Paul Shekelle; Robert Hopkins; Mary Ann Forciea; Douglas K Owens
Journal:  Ann Intern Med       Date:  2008-05-06       Impact factor: 25.391

3.  Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.

Authors:  Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Maureen G Phipps; Michael Pignone; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2018-06-26       Impact factor: 56.272

4.  Survival after hip fracture: short- and long-term excess mortality according to age and gender.

Authors:  L Forsén; A J Sogaard; H E Meyer; T Edna; B Kopjar
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

5.  The near absence of osteoporosis treatment in older men with fractures.

Authors:  Adrianne C Feldstein; Gregory Nichols; Eric Orwoll; Patricia J Elmer; David H Smith; Michael Herson; Mikel Aickin
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

6.  Estimation of the lifetime risk of hip fracture for women and men in Canada.

Authors:  R B Hopkins; E Pullenayegum; R Goeree; J D Adachi; A Papaioannou; W D Leslie; J E Tarride; L Thabane
Journal:  Osteoporos Int       Date:  2011-05-11       Impact factor: 4.507

Review 7.  Secular trends in the incidence of hip and other osteoporotic fractures.

Authors:  C Cooper; Z A Cole; C R Holroyd; S C Earl; N C Harvey; E M Dennison; L J Melton; S R Cummings; J A Kanis
Journal:  Osteoporos Int       Date:  2011-04-02       Impact factor: 4.507

8.  Osteoporosis in men: an Endocrine Society clinical practice guideline.

Authors:  Nelson B Watts; Robert A Adler; John P Bilezikian; Matthew T Drake; Richard Eastell; Eric S Orwoll; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2012-06       Impact factor: 5.958

9.  Screening for osteoporosis in men aged 70 years and older in a primary care setting in the United States.

Authors:  Sian Yik Lim; Joon Hee Lim; Dan Nguyen; Rie Okamura; Hoda Mojazi Amiri; Michael Calmes; Kenneth Nugent
Journal:  Am J Mens Health       Date:  2013-02-25

10.  Clinical risk factors, bone density and fall history in the prediction of incident fracture among men and women.

Authors:  M H Edwards; K Jameson; H Denison; N C Harvey; A Aihie Sayer; E M Dennison; C Cooper
Journal:  Bone       Date:  2012-11-13       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.